The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
Authors:
- Gunter WolfGWGunter Wolf
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 33 (1) , 44-53
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- The Link Between the Renin-Angiotensin-Aldosterone System and Renal Injury in Obesity and the Metabolic SyndromeCurrent Hypertension Reports, 2012
- Involvement of glomerular renin−angiotensin system (RAS) activation in the development and progression of glomerular injuryClinical and Experimental Nephrology, 2011
- The renin–angiotensin–aldosterone system and glucose homeostasisTrends in Pharmacological Sciences, 2011
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled studyDiabetologia, 2011
- New insights and perspectives on intrarenal renin-angiotensin system: Focus on intracrine/intracellular angiotensin IIPeptides, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- The Role of Renin-Angiotensin Agents in Altering the Natural History of Type 2 Diabetes MellitusCurrent Cardiology Reports, 2010
- Adipose Tissue–Specific Regulation of Angiotensinogen in Obese Humans and Mice: Impact of Nutritional Status and Adipocyte HypertrophyAmerican Journal of Hypertension, 2010
- Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high saltKidney International, 2009
- Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityNature Medicine, 2007